Science and Technology

Personalized medicine aims to tailor prevention, diagnosis, and treatment to the unique biological, environmental, and lifestyle characteristics of each patient. Over the past decade, this approach has moved from concept to practice, reshaping how therapies are developed and how clinical trials are designed. Advances in genomics, data science, and digital health are accelerating this transformation, while regulatory agencies and healthcare systems adapt to support more precise and patient-centered research models.Genomics and Multi-Omics at the Heart of AdvancementThe steep drop in genome sequencing costs, paired with the expanding use of multi-omics approaches, has significantly transformed personalized medicine.Genomics: Through whole-genome and exome…

Drug discovery has traditionally been a slow, expensive, and high-risk process, often taking more than a decade and billions of dollars to bring a single therapy to market. Recent advances in artificial intelligence and protein folding tools are reshaping this landscape by dramatically improving how scientists understand biological targets, design drug candidates, and predict outcomes. Together, these technologies are compressing timelines, lowering costs, and opening therapeutic opportunities that were previously out of reach.The Essential Importance of Protein Architecture in Contemporary Drug DevelopmentMost medications exert their effects by attaching to specific proteins and modifying how those proteins function, and creating potent…

Drug discovery has traditionally been a slow, expensive, and high-risk process, often taking more than a decade and billions of dollars to bring a single therapy to market. Recent advances in artificial intelligence and protein folding tools are reshaping this landscape by dramatically improving how scientists understand biological targets, design drug candidates, and predict outcomes. Together, these technologies are compressing timelines, lowering costs, and opening therapeutic opportunities that were previously out of reach.The Essential Importance of Protein Architecture in Contemporary Drug DevelopmentMost medications exert their effects by attaching to specific proteins and modifying how those proteins function, and creating potent…

Digital biomarkers are objective, quantifiable physiological and behavioral data collected through digital devices such as smartphones, wearable sensors, and connected medical tools. Unlike traditional biomarkers, which often rely on laboratory tests or in-clinic measurements, digital biomarkers are generated continuously in real-world settings. They capture signals like heart rhythm, physical activity, sleep patterns, voice characteristics, typing behavior, and movement dynamics, transforming everyday interactions with technology into health insights.Shifting from Occasional Treatment to Ongoing MonitoringConventional health checkups usually occur sporadically through infrequent clinic appointments and brief diagnostic evaluations, while digital biomarkers move this approach toward ongoing monitoring. Around-the-clock tracking from wearable devices…

Zero-knowledge proofs, or ZKPs, first emerged within academic cryptography and later entered the public spotlight through blockchain technology and privacy-driven cryptocurrencies. Their fundamental appeal lies in a remarkable idea: a party can verify the truth of a claim without disclosing the data that substantiates it. As organizations confront increasing demands to safeguard confidential information, meet rigorous regulatory requirements, and still operate collaboratively across different entities, this approach is becoming valuable well beyond digital asset ecosystems.A practical view of zero-knowledge proofsAt an enterprise scale, ZKPs support credible trust while revealing almost nothing. Rather than sharing raw information, organizations can offer proofs…

Satellite internet has moved from a niche solution for remote locations to a cornerstone of next-generation connectivity. Falling launch costs, advances in satellite design, and tighter integration with terrestrial networks are reshaping how data is delivered globally. The result is a faster, more resilient, and more inclusive connectivity ecosystem that complements fiber, 5G, and future 6G networks.Low Earth Orbit Constellations Transform Performance StandardsThe most transformative trend is the rise of Low Earth Orbit (LEO) satellite constellations. Orbiting at altitudes of roughly 300 to 1,200 kilometers, LEO satellites dramatically reduce latency compared to traditional geostationary satellites positioned 35,786 kilometers above Earth.Major…